A Study to Evaluate Chronic Hepatitis C Infection
Study description
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered With Ribavirin (RBV) in Treatment-Naïve Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (SAPPHIRE-I)
Pathology
Hepatitis C Virus HCV
Study type
Clinical trial
Status
Terminated
Study start date
2012
Study completion date
2015
Funder Type
Industry funded study
Investigator
Dr. med. Lorenzo MAGENTA
Recruitment
Completed